Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis

por Valerio, Maria Rosaria, Spadaro, Pietro, Arcanà, Concetta, Borsellino, Nicolò, Cipolla, Calogero, Vigneri, Paolo, Piazza, Dario, Gebbia, Vittorio
Publicado 2021

Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study

por Adamo, Vincenzo, Ricciardi, Giuseppina Rosaria Rita, Giuffrida, Dario, Scandurra, Giuseppa, Russo, Antonio, Blasi, Livio, Spadaro, Pietro, Iacono, Carmelo, Soto Parra, Hector J., Savarino, Antonino, Ferraú, Francesco, Zerilli, Filippo, Verderame, Francesco, Butera, Alfredo, Santangelo, Carlo, Franchina, Veronica, Caruso, Michele
Publicado 2019